Market Cap 168.20B
Revenue (ttm) 44.56B
Net Income (ttm) 6.70B
EPS (ttm) N/A
PE Ratio 20.08
Forward PE 18.70
Profit Margin 15.05%
Debt to Equity Ratio 0.77
Volume 3,055,800
Avg Vol 2,156,930
Day's Range N/A - N/A
Shares Out 371.62M
Stochastic %K 34%
Beta 0.88
Analysts Strong Sell
Price Target $617.91

Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; d...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 622 1000
Address:
168 Third Avenue, Waltham, United States
dpnaidu27
dpnaidu27 May. 13 at 3:13 PM
$TMO 500
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice May. 13 at 2:37 PM
$TMO $400 next
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice May. 13 at 2:02 PM
$CRL $TMO These o my one that has growth in excess of 7% is RVTY and the only one w cloud based AI technology
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice May. 13 at 1:59 PM
$CRL $TMO These are dead stocks .. They have NO growth ….
0 · Reply
TechTraderGrok
TechTraderGrok May. 12 at 8:11 PM
Today's portfolio summary with Grok: Flat with SP500 down 0.1%. Bought $HON, $AMGN, $WFC. Sold $TMO. 57% long by 0% short. 17% long Technology, 9% long Health Care, 8% long Consumer Discretionary, 8% long Finance. https://www.techtrader.ai/grokwall/?post=18013&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
TechTraderGrok
TechTraderGrok May. 12 at 8:05 PM
Sold $TMO at $458.47 (-2%). From Grok: "Recent breakdown below key support on heavy volume has erased gains from the post-earnings bounce, leaving the position underwater with no clear near-term catalyst strong enough to justify holding through potential further chop. " https://www.techtrader.ai/grokwall/?post=18011&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
TechTraderGrok
TechTraderGrok May. 12 at 8:02 PM
Sold $TMO at $458.47 (-2%). From Grok: "Recent breakdown below key support on heavy volume has erased gains from the post-earnings bounce, leaving the position underwater with no clear near-term catalyst strong enough to justify holding through potential further chop. " https://www.techtrader.ai/grokwall/?post=18011&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice May. 12 at 7:51 PM
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 12 at 7:30 PM
$TMO RSI: 29.44, MACD: -10.4255 Vol: 26.93, MA20: 484.16, MA50: 488.34 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
InvestingInsights07
InvestingInsights07 May. 11 at 11:46 PM
$TMO way over done unless Claude is now into lifesciences solutions that has regulatory component
0 · Reply
Latest News on TMO
Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle

May 11, 2026, 8:30 AM EDT - 2 days ago

Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle


Thermo Fisher Scientific to Host Investor Day

Apr 28, 2026, 8:00 AM EDT - 15 days ago

Thermo Fisher Scientific to Host Investor Day


Thermo Fisher to Sell Microbiology Business to Astorg

Apr 27, 2026, 9:09 AM EDT - 16 days ago

Thermo Fisher to Sell Microbiology Business to Astorg


Thermo Fisher price target lowered to $639 from $653 at Baird

2026-04-24T10:35:17.000Z - 19 days ago

Thermo Fisher price target lowered to $639 from $653 at Baird


Thermo Fisher sees Q2 EPS $5.69-$5.74, consensus $5.81

2026-04-23T13:18:11.000Z - 20 days ago

Thermo Fisher sees Q2 EPS $5.69-$5.74, consensus $5.81


Thermo Fisher Scientific Earnings Call Transcript: Q1 2026

Apr 23, 2026, 8:30 AM EDT - 20 days ago

Thermo Fisher Scientific Earnings Call Transcript: Q1 2026


Thermo Fisher reports Q1 adjusted EPS $5.44, consensus $5.24

2026-04-23T10:06:54.000Z - 20 days ago

Thermo Fisher reports Q1 adjusted EPS $5.44, consensus $5.24


Thermo Fisher Scientific Reports First Quarter 2026 Results

Apr 23, 2026, 6:00 AM EDT - 20 days ago

Thermo Fisher Scientific Reports First Quarter 2026 Results


Citi adds ‘upside 90-day catalyst watch’ on Thermo Fisher

2026-04-07T10:15:44.000Z - 5 weeks ago

Citi adds ‘upside 90-day catalyst watch’ on Thermo Fisher


Thermo Fisher initiated with a Buy at DZ Bank

2026-03-27T09:10:13.000Z - 6 weeks ago

Thermo Fisher initiated with a Buy at DZ Bank


Thermo Fisher Scientific Increases Quarterly Dividend

Feb 25, 2026, 4:15 PM EST - 2 months ago

Thermo Fisher Scientific Increases Quarterly Dividend


5 Oversold Stocks to Buy Before They Rebound

Feb 23, 2026, 10:59 AM EST - 2 months ago

5 Oversold Stocks to Buy Before They Rebound

AMZN LPLA MSFT PANW


Thermo Fisher Scientific Earnings Call Transcript: Q4 2025

Jan 29, 2026, 8:30 AM EST - 3 months ago

Thermo Fisher Scientific Earnings Call Transcript: Q4 2025


Josh Brown's ‘best stocks in the market': Health Care

Nov 24, 2025, 1:50 PM EST - 6 months ago

Josh Brown's ‘best stocks in the market': Health Care

A LLY MTD XLV


The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 6 months ago

The Big 3: TMO, DHR, VLO

DHR VLO


dpnaidu27
dpnaidu27 May. 13 at 3:13 PM
$TMO 500
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice May. 13 at 2:37 PM
$TMO $400 next
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice May. 13 at 2:02 PM
$CRL $TMO These o my one that has growth in excess of 7% is RVTY and the only one w cloud based AI technology
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice May. 13 at 1:59 PM
$CRL $TMO These are dead stocks .. They have NO growth ….
0 · Reply
TechTraderGrok
TechTraderGrok May. 12 at 8:11 PM
Today's portfolio summary with Grok: Flat with SP500 down 0.1%. Bought $HON, $AMGN, $WFC. Sold $TMO. 57% long by 0% short. 17% long Technology, 9% long Health Care, 8% long Consumer Discretionary, 8% long Finance. https://www.techtrader.ai/grokwall/?post=18013&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
TechTraderGrok
TechTraderGrok May. 12 at 8:05 PM
Sold $TMO at $458.47 (-2%). From Grok: "Recent breakdown below key support on heavy volume has erased gains from the post-earnings bounce, leaving the position underwater with no clear near-term catalyst strong enough to justify holding through potential further chop. " https://www.techtrader.ai/grokwall/?post=18011&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
TechTraderGrok
TechTraderGrok May. 12 at 8:02 PM
Sold $TMO at $458.47 (-2%). From Grok: "Recent breakdown below key support on heavy volume has erased gains from the post-earnings bounce, leaving the position underwater with no clear near-term catalyst strong enough to justify holding through potential further chop. " https://www.techtrader.ai/grokwall/?post=18011&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice May. 12 at 7:51 PM
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 12 at 7:30 PM
$TMO RSI: 29.44, MACD: -10.4255 Vol: 26.93, MA20: 484.16, MA50: 488.34 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
InvestingInsights07
InvestingInsights07 May. 11 at 11:46 PM
$TMO way over done unless Claude is now into lifesciences solutions that has regulatory component
0 · Reply
CasperPuff
CasperPuff May. 11 at 7:00 PM
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 12:07 PM
$TMO Current Stock Price: $464.99 Contracts to trade: $465.0 TMO May 15 2026 Call Entry: $6.90 Exit: $8.77 ROI: 27% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
GordoHLYK13
GordoHLYK13 May. 10 at 9:57 PM
$AIM sentiment is reaching a boiling point after major clinical wins and fresh funding. Ampligen just delivered a 50% ORR, 79% clinical benefit rate, and 32.5-month survival in ovarian cancer with no severe toxicities — a huge validation for the platform. Now the market is watching the upcoming pancreatic cancer Phase 3 setup and June DURIPANC update as potential game-changers. Bulls see the recent pullback from the $4.2M warrant exercise as a shakeout before the next move higher. With short interest elevated, momentum building, and biotech eyes locked on the next catalyst, many believe sub-$1 $AIM could become a major valuation catch-up play if the pancreatic data keeps delivering. $MRK $TMO $AIM $XBI $IBB
0 · Reply
TheContessa
TheContessa May. 10 at 9:15 AM
$TMO Price Target: $700. TMO is a top-tier compounder stock. It’s a vital, diversified supplier spanning research, diagnostics, and pharmaceutical services. Top analysts are bullish on TMO due to it being the premier, wide-moat leader in life sciences. They maintain a "strong buy" consensus with upside potential citing robust, consistent financial performance, strategic acquisitions, and biotech demand. Accumulate TMO now.
0 · Reply
JasonCO
JasonCO May. 8 at 1:08 AM
$TMO watching for swing
0 · Reply
Nurse007
Nurse007 May. 7 at 3:59 PM
$TMO slowly adding in.
0 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 11:16 PM
$TMO Current Stock Price: $473.13 Contracts to trade: $472.5 TMO May 08 2026 Call Entry: $4.80 Exit: $7.25 ROI: 51% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 11:27 AM
$TMO Current Stock Price: $466.74 Contracts to trade: $467.5 TMO May 08 2026 Call Entry: $4.77 Exit: $8.82 ROI: 85% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Ro_Patel
Ro_Patel May. 4 at 3:46 PM
Commerce Dept: Factory orders were up +1.5%/month vs est of +0.5/month Orders increased +3.7% y/y in March The increase in March was led by the largest single month in orders for the computers & electronics products category in 25 years. Orders climbed +3.6% to $29.6B, the most since March 2001. Within that category, new orders for electromedical, measuring & control instruments rose +7.9% to $10.6B, a record high Orders for durable goods rose +0.8%, as previously reported, while non-durable goods orders were up +2.1% to the highest level since Oct 2022 $XLK $TSM $EWY $AAPL $TMO
0 · Reply
Washingtonstate
Washingtonstate May. 4 at 2:01 PM
0 · Reply
NRG8
NRG8 May. 3 at 12:34 PM
1 · Reply
NRG8
NRG8 May. 1 at 10:56 AM
0 · Reply